XPO5 and cancer: Pin1 mediates the twist of XPO5 Ser497-Pro to block XPO5 activity, thereby impeding miRNAs biogenesis and promoting HCC development.3 These findings make Pin1 an attractive target for cancer therapy and induce the discovery of Pin1-targeted inhibitors.